About GADODIAMID E 0.5MMOL/ML
Gadolinium-based MRI contrast agent
Used for
- Enhances MRI images of the brain, spine, and other body areas.
- Helps detect or assess abnormal tissues and blood vessels.
Usual adult dose
Usually 0.1 mmol/kg intravenously for each MRI examination.
Usual dose in children
Usually 0.1 mmol/kg intravenously; use depends on age and local product guidance.
Common side effects
- Headache
- Nausea
- Dizziness
- Injection-site discomfort
Important warnings
- Can cause serious kidney-related systemic fibrosis, especially with severe kidney impairment.
- Rarely causes severe allergic reactions.
- Use the lowest effective dose; avoid repeat doses unless needed.
- Risk of gadolinium retention increases after repeated exposure.
Pregnancy
Avoid during pregnancy unless imaging is essential; gadolinium may cross the placenta.
Breastfeeding
Very small amounts may enter milk; professional guidance generally permits continuing breastfeeding after administration.
Interactions
- Other gadolinium contrast agents may increase exposure if given close together.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.